Virax Biolabs Group Ltd Selling Expense
Virax Biolabs Group Ltd (VRAX) reported Selling Expense of $26.62 thousand for the 12-month period ending 2023-03-31, per its 20-F filed 2023-06-14.
Discontinued › Expense Statement
ifrs-full:SellingExpense · last filed 2023-06-14
| Period end | Selling Expense 12 month |
|---|---|
| 2023-03-31 | $26.62K 20-F · filed 2023-06-14 |
| 2022-03-31 | $13.82K 20-F · filed 2023-06-14 |
| 2021-03-31 | $57.20K 20-F · filed 2022-08-12 |